EI
AGIO icon

Ellevest Inc’s Agios Pharmaceuticals AGIO Stock Holding History

Ellevest Inc’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8
Closed – – 1835
2022
Q3 		$0 Buy
+8
New +$215 ﹤0.01% 1577
2022
Q2 		– Sell
-7
Closed – – 1370
2022
Q1 		$0 Buy
+7
New +$214 ﹤0.01% 1388
2020
Q2 		– Sell
-50
Closed -$2K – 1110
2020
Q1 		$2K Buy
+50
New +$2.31K ﹤0.01% 739
2019
Q3 		– Sell
-17
Closed -$1K – 500
2019
Q2 		$1K Buy
+17
New +$909 ﹤0.01% 359

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ellevest Inc's AGIO Position: Q4 2022 in Review

Ellevest Inc sold out of Agios Pharmaceuticals (AGIO) in Q4 2022, closing a stake of 8 shares.

Ellevest Inc first reported a position in AGIO in Q2 2019 and held it in 4 quarters. The position peaked at $2K in Q1 2020. 159 funds tracked by Wall St. Rank hold AGIO as of Q4 2022.

  • Ellevest Inc reported no remaining Agios Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Ellevest Inc sold 8 Agios Pharmaceuticals shares in Q4 2022.
  • Ellevest Inc first reported a position in Agios Pharmaceuticals in Q2 2019 and held it in 4 quarters.
  • Ellevest Inc's Agios Pharmaceuticals position peaked at $2K in Q1 2020.
  • 159 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.